GREENLIGHT CAPITAL RE, LTD. (GLRE) FY 2024 MD&A
This page reproduces the company's own Item 7 MD&A text from the linked SEC filing. It is filer text, not grepcent analysis, scoring, or investment advice.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following is management’s discussion and analysis (“MD&A”) of the financial condition and results of operations for the years ended December 31, 2024, and 2023. Except for the “Results by Segment” section of this MD&A, comparisons between 2023 and 2022 have been omitted from this Annual Report, but may be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC. Accordingly, this information is incorporated by reference.
This discussion and analysis should be read in conjunction with our audited consolidated financial statements and notes thereto presented in “Part II, Item 8. Financial Statements and Supplementary Data” of this Annual Report. Unless otherwise noted, tabular dollars are in thousands, except per share amounts. Amounts may not reconcile due to rounding differences.
Page
| Overview | 51 |
|---|---|
| Business Overview | 51 |
| Outlook and Trends | 51 |
| Revenues and Expenses | 51 |
| Key Financial Measures and Non-GAAP Measures | 52 |
| Consolidated Results of Operations | 54 |
| Results by Segment | 56 |
| Open Market Segment | 56 |
| Innovations Segment | 59 |
| Other Corporate | 61 |
| Runoff Underwriting Business | 61 |
| Income from Investment in Solasglas | 61 |
| Financial Condition | 62 |
| Liquidity and Capital Resources | 64 |
| Liquidity | 64 |
| Capital Resources | 65 |
| Contractual Obligations and Commitments | 66 |
| Critical Accounting Estimates | 67 |
| Premium Recognition | 67 |
| Loss and LAE Reserves | 68 |
| Investments Valuation | 70 |
50
Return to table of contents
Overview
Business Overview
We are a global specialty property and casualty reinsurer headquartered in the Cayman Islands, with an underwriting and investment strategy that we believe differentiates us from most of our competitors. Our goal is to build long-term shareholder value by providing risk management solutions to the insurance, reinsurance, and other risk marketplaces. Refer to “Part 1, Item 1. Business” for additional information.
We earned a net income of $42.8 million for the year ended December 31, 2024, a decrease of $44.0 million, or 51% compared to the prior year, predominantly due to higher losses from catastrophe and weather-related events (collectively referred as “CAT losses”), coupled with unfavorable foreign exchange movement in 2024.
The following is a summary of our financial performance for the year ended December 31, 2024, compared to the prior year:
•Gross premiums written was $698.3 million, an increase of 9.7%;
•Net premiums earned was $620.0 million, an increase of 6.3%;
•Net underwriting loss was $8.2 million, compared to net underwriting income of $32.0 million;
•Total investment income was $79.6 million, an increase of 10.3% (including 9.8% net return from our investment in Solasglas, compared to 9.4%);
•Foreign exchange losses were $5.6 million, compared to foreign exchange gains of $11.6 million;
•Diluted EPS was $1.24, compared to $2.50, a decrease of 50%; and
•Fully diluted book value per share was $17.95, an increase of $1.21, or 7.2%.
Outlook and Trends
Reinsurance market conditions
As the key January 1, 2025, renewal period progressed, we saw increased competition which put pressure on headline rate; however, attachment points and other terms & conditions largely held firm. We were able to achieve signings to construct a diversified portfolio that met our risk appetite and profitability requirements. Looking forward to 2025, we believe that market conditions are still broadly, but not uniformly, positive. We will continue to write business where we believe the price adequately compensates us for the risk.
General economic conditions
There are many factors contributing to an uncertain global economic outlook, and in particular, we believe that inflationary trends of recent years could persist. We continue to consider the potential impact of relevant economic factors on our underwriting portfolio. On the investment side, DME Advisors regularly monitors and re-positions Solasglas’ investment portfolio to manage the impact of inflation on its underlying investments and holds macro positions to benefit from a rising inflationary environment.
Revenues and Expenses
Revenues
We derive our revenues from two principal sources:
•premiums from reinsurance on property and casualty business assumed (net of any premiums ceded) - see “Critical Accounting Estimates” section of this MD&A; and
•income from investments, including:
•income (or loss) generated from our investment in Solasglas, net of management fee and performance compensation;
•gains (or losses) from our other investments, including Innovations-related investments; and
•interest income on our cash and cash equivalents and FAL.
51
Return to table of contents
In addition, we may from time to time derive other income from foreign exchange gains (or losses) relating to underwriting balances, net investment income from Lloyd’s syndicates, fees generated from advisory services, and fees relating to overrides, profit commissions, and fees due upon the early termination of contracts.
Expenses
Our expenses consist primarily of the following:
| ● | underwriting losses and LAE; | |
|---|---|---|
| ● | acquisition costs; | |
| ● | underwriting expenses | |
| ● | corporate and other expenses; and | |
| ● | interest expense on deposit-accounted contracts and debt. |
The extent of our net losses and LAE incurred is a function of the amount and type of reinsurance contracts we write and the loss experience of the underlying coverage. Refer to “Critical Accounting Estimates” section of this MD&A.
Acquisition costs consist primarily of brokerage fees, ceding commissions, premium taxes, profit commissions, letters of credit and trust fees, and federal excise taxes. We amortize deferred acquisition costs relating to successfully bound reinsurance contracts over the related contract term.
Underwriting expenses consist primarily of compensation costs related to our underwriting activities, in addition to an allocation of corporate overhead costs.
Corporate and other expenses consist primarily of compensation costs related to non-underwriting activities, including Innovations related investments and corporate personnel. Additionally, these also include professional fees (non-claim related), travel and entertainment, information technology, rent, and other general operating costs, net of an allocation to underwriting expenses.
Deposit interest expense relates to the accretion costs for deposit-accounted contracts that did not meet the risk transfer condition for reinsurance accounting under U.S. GAAP.
Interest expense consists of interest paid and accrued on our debt and the amortization of the related deferred financing costs.
Key Financial Measures and Non-GAAP Measures
Management uses certain key financial measures, some of which are not prescribed under U.S. GAAP rules and standards (“non-GAAP financial measures”), to evaluate our financial performance, financial position, and the change in shareholder value. Generally, a non-GAAP financial measure, as defined in SEC Regulation G, is a numerical measure of a company’s historical or future financial performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented under U.S. GAAP. We believe that these measures, which may be calculated or defined differently by other companies, provide consistent and comparable metrics of our business performance to help shareholders understand performance trends and facilitate a more thorough understanding of the Company’s business. Non-GAAP financial measures should not be viewed as substitutes for those determined under U.S. GAAP.
We use the following non-GAAP financial measure in this Annual Report.
Fully Diluted Book Value Per Share
Our primary financial goal is to increase fully diluted book value per share over the long term. We use fully diluted book value as a financial measure in our incentive compensation plan.
We believe that long-term growth in fully diluted book value per share is the most relevant measure of our financial performance because it provides management and investors a yardstick to monitor the shareholder value generated. Fully diluted book value per share may also help our investors, shareholders, and other interested parties form a basis of comparison with other companies within the property and casualty reinsurance industry. Fully diluted book value per share should not be viewed as a substitute for the most comparable U.S. GAAP measure, which in our view is the basic book value per share.
52
Return to table of contents
We calculate basic book value per share as (a) ending shareholders' equity, divided by (b) the total ordinary shares issued and outstanding, as reported in the consolidated financial statements.
Fully diluted book value per share represents basic book value per share combined with any dilutive impact of in-the-money stock options and all outstanding restricted stock units, or “RSUs”. We believe these adjustments better reflect the ultimate dilution to our shareholders.
The following table presents a reconciliation of the fully diluted book value per share to basic book value per share (the most directly comparable U.S. GAAP financial measure):
| December 31, 2024 | December 31, 2023 | December 31, 2022 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Numerator for basic and fully diluted book value per share: | ||||||||||
| Total equity as reported under U.S. GAAP | $ | 635,879 | $ | 596,095 | $ | 503,120 | ||||
| Denominator for basic and fully diluted book value per share: | ||||||||||
| Ordinary shares issued and outstanding as reported and denominator for basic book value per share | 34,831,324 | 35,336,732 | 34,824,061 | |||||||
| Add: In-the-money stock options (1) and all outstanding RSUs | 590,001 | 264,870 | 277,960 | |||||||
| Denominator for fully diluted book value per share | 35,421,325 | 35,601,602 | 35,102,021 | |||||||
| Basic book value per share | $ | 18.26 | $ | 16.87 | $ | 14.45 | ||||
| Increase in basic book value per share ($) | $ | 1.39 | $ | 2.42 | $ | 0.40 | ||||
| Increase in basic book value per share (%) | 8.2 | % | 16.8 | % | 2.8 | % | ||||
| Fully diluted book value per share | $ | 17.95 | $ | 16.74 | $ | 14.33 | ||||
| Increase in fully diluted book value per share ($) | $ | 1.21 | $ | 2.41 | $ | 0.34 | ||||
| Increase in fully diluted book value per share (%) | 7.2 | % | 16.8 | % | 2.4 | % |
(1) Assuming net exercise by the grantee.
53
Return to table of contents
Consolidated Results of Operations
The table below summarizes our consolidated operating results.
| 2024 | 2023 | Change | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Underwriting results: | |||||||||||
| Gross premiums written | $ | 698,335 | $ | 636,810 | $ | 61,525 | |||||
| Net premiums written | $ | 621,265 | $ | 594,048 | $ | 27,217 | |||||
| Net premiums earned | $ | 619,954 | $ | 583,147 | $ | 36,807 | |||||
| Net loss and LAE incurred: | |||||||||||
| Current year | (406,465) | (348,798) | (57,667) | ||||||||
| Prior year (1) | (20,804) | (11,206) | (9,598) | ||||||||
| Net loss and LAE incurred | (427,269) | (360,004) | (67,265) | ||||||||
| Acquisition costs | (176,775) | (168,877) | (7,898) | ||||||||
| Underwriting expenses | (22,857) | (19,587) | (3,270) | ||||||||
| Deposit interest income (expense), net | (1,228) | (2,687) | 1,459 | ||||||||
| Net underwriting income (loss) | (8,175) | 31,992 | (40,167) | ||||||||
| Investment results: | |||||||||||
| Income from investment in Solasglas | 33,605 | 28,696 | 4,909 | ||||||||
| Net investment income | 45,954 | 43,408 | 2,546 | ||||||||
| Total investment income | 79,559 | 72,104 | 7,455 | ||||||||
| Corporate and other expenses | (16,377) | (23,653) | 7,276 | ||||||||
| Foreign exchange gains (losses) | (5,606) | 11,566 | (17,172) | ||||||||
| Other income, net | — | 265 | (265) | ||||||||
| Interest expense | (5,836) | (5,344) | (492) | ||||||||
| Income tax expense | (749) | (100) | (649) | ||||||||
| Net income | $ | 42,816 | $ | 86,830 | $ | (44,014) | |||||
| Diluted earnings per share | $ | 1.24 | $ | 2.50 | $ | (1.26) | |||||
| Underwriting ratios: | |||||||||||
| Current year attritional loss ratio | 56.3 | % | 54.9 | % | 1.4 | % | |||||
| CAT loss ratio | 9.3 | % | 4.9 | % | 4.4 | % | |||||
| Current year loss ratio | 65.6 | % | 59.8 | % | 5.8 | % | |||||
| Prior year reserve development ratio | 3.4 | % | 1.9 | % | 1.5 | % | |||||
| Loss ratio | 69.0 | % | 61.7 | % | 7.3 | % | |||||
| Acquisition cost ratio | 28.5 | % | 29.0 | % | (0.5) | % | |||||
| Composite ratio | 97.5 | % | 90.7 | % | 6.8 | % | |||||
| Underwriting expense ratio | 3.9 | % | 3.8 | % | 0.1 | % | |||||
| Combined ratio | 101.4 | % | 94.5 | % | 6.9 | % |
1 The net financial impact associated with changes in the estimate of losses incurred in prior years, which incorporates earned reinstatement premiums assumed and ceded, adjustments to assumed and ceded acquisition costs, and deposit interest income and expense, was a loss of $21.8 million in 2024 (2023: $15.7 million).
54
Return to table of contents
Consolidated Results of Operations for 2024 compared to 2023
Basic book value per share increased by $1.39 per share, or 8.2%, to $18.26 per share from $16.87 per share at December 31, 2023. Fully diluted book value per share increased by $1.21 per share, or 7.2%, to $17.95 per share from $16.74 per share at December 31, 2023.
For the year ended December 31, 2024, net income decreased by $44.0 million to $42.8 million, driven mainly by the following:
•Underwriting income: Decreased by $40.2 million due to 6.9 percentage points increase in our combined ratio, driven predominantly by an increase in current year attritional and CAT loss ratios. Refer to the “Results by Segment” section of the MD&A for further discussion and analysis.
.
•Investment income: Increased by $7.5 million primarily driven by an increase in income from our investment in Solasglas, which reported a gain of $33.6 million in 2024, compared to $28.7 million in 2023. Solasglas generated a net return of 9.8% for the year ended December 31, 2024, compared to a net return of 9.4% for the same period in 2023. Additionally, we earned additional investment income on funds withheld by third party Lloyd’s syndicates. The Lloyd’s syndicates invest a portion of these funds in fixed maturity securities, equities, and investment funds. We record our share of the investment income and fair value adjustments on these securities when the syndicates report them to us, generally on a quarter in arrears. See Note 13 “Net Investment Income” of the consolidated financial financial statements for further details.
•Corporate and other expenses: Decreased by $7.3 million mainly due to non-recurring severance costs included in 2023, including $4.3 million relating to the separation agreement entered with our former CEO, and lower incentive compensation costs in light of the Company’s weaker performance in 2024. This was partially offset by the increase in other non-underwriting personnel and overhead costs in addition to technology investment to support the business growth.
•Foreign exchange gains (losses): $5.6 million foreign exchange losses for 2024, compared to $11.6 million foreign exchange gains for 2023, driven mainly by a weaker pound sterling movement against the U.S. dollar in 2024.
•Interest expense: Increased by $0.5 million primarily due to unfavorable fair value movement on the interest rate swaps used to partially hedge the Term Loans; offset partially by lower interest expense driven by a decrease in the average outstanding Term Loans balance in 2024.
55
Return to table of contents
Results by Segment
During the fourth quarter of 2024, we have revised our operating segments to Open Market and Innovations. See Note 17 “Segment Reporting” for the consolidated segment net income before taxes in 2024, including a reconciliation to net income as reported under U.S. GAAP. Comparatives have been recast to conform with the new reportable segments.
The following is a further discussion and analysis for each reporting segment.
Open Market Segment
Results for the Open Market segment were as follows:
| Year ended December 31, | 2024 | % Change | 2023 | % Change | 2022 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross premiums written | $ | 603,798 | 19.7 | % | $ | 504,435 | 11.5 | % | $ | 452,541 | |||||||
| Net premiums written | $ | 541,446 | 16.1 | % | $ | 466,544 | 6.6 | % | $ | 437,799 | |||||||
| Net premiums earned | $ | 511,922 | 9.7 | % | $ | 466,751 | 13.6 | % | $ | 410,877 | |||||||
| Net loss and LAE incurred | (341,586) | (262,290) | (268,659) | ||||||||||||||
| Acquisition costs | (144,852) | (136,356) | (125,296) | ||||||||||||||
| Other underwriting expenses | (19,175) | (16,827) | (11,867) | ||||||||||||||
| Deposit interest expense, net | (1,228) | (2,687) | (6,717) | ||||||||||||||
| Underwriting income (loss) | 5,081 | 48,591 | (1,662) | ||||||||||||||
| Net investment income | 42,629 | 14.1 | % | 37,351 | 662.6 | % | 4,898 | ||||||||||
| Income before income taxes | $ | 47,710 | $ | 85,942 | $ | 3,236 | |||||||||||
| Underwriting ratios: | 2024 | % Point Change | 2023 | % Point Change | 2022 | ||||||||||||
| Loss ratio | 66.7 | % | 10.5 | % | 56.2 | % | (9.2) | % | 65.4 | % | |||||||
| Acquisition cost ratio | 28.3 | % | (0.9) | % | 29.2 | % | (1.3) | % | 30.5 | % | |||||||
| Composite ratio | 95.0 | % | 9.6 | % | 85.4 | % | (10.5) | % | 95.9 | % | |||||||
| Underwriting expenses ratio | 4.0 | % | (0.2) | % | 4.2 | % | (0.3) | % | 4.5 | % | |||||||
| Combined ratio | 99.0 | % | 9.4 | % | 89.6 | % | (10.8) | % | 100.4 | % |
Gross Premiums Written
Gross premiums written by line of business were as follows:
| % Change | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2024 to 2023 | 2023 to 2022 | |||||||||||||||||||||||
| Casualty | $ | 92,471 | 15.3 | % | $ | 86,081 | 17.1 | % | $ | 82,524 | 18.2 | % | 7.4 | % | 4.3 | % | |||||||||||
| Financial | 63,679 | 10.5 | % | 46,296 | 9.2 | % | 63,452 | 14.0 | % | 37.5 | % | (27.0) | % | ||||||||||||||
| Health | 217 | — | % | 224 | — | % | 227 | 0.1 | % | (3.1) | % | (1.3) | % | ||||||||||||||
| Multiline | 181,140 | 30.0 | % | 198,037 | 39.3 | % | 205,743 | 45.5 | % | (8.5) | % | (3.7) | % | ||||||||||||||
| Property | 87,922 | 14.6 | % | 75,820 | 15.0 | % | 31,347 | 6.9 | % | 16.0 | % | 141.9 | % | ||||||||||||||
| Specialty | 178,369 | 29.6 | % | 97,977 | 19.4 | % | 69,248 | 15.3 | % | 82.1 | % | 41.5 | % | ||||||||||||||
| Total | $ | 603,798 | 100.0 | % | $ | 504,435 | 100.0 | % | $ | 452,541 | 100.0 | % | 19.7 | % | 11.5 | % |
Gross premiums written in 2024 increased by $99.4 million or 19.7%, compared to 2023. The increase was predominantly attributable to the following lines of business:
•Financial: new excess of loss treaties in our financial multiline business and an increase in premium volume for our transactional liability business.
•Property: improved pricing in our commercial and property catastrophe business.
56
Return to table of contents
•Specialty: improved pricing and new customers in our marine and energy (M&E) business, including Lloyd’s whole account excess of loss treaties. Additionally, there was an increase of $9.0 million in reinstatement premiums attributable to the 2024 CAT events, in particular for the Baltimore Bridge collapse.
The above was partially offset by the decrease in our multiline business, driven by two non-renewed FAL accounts on January 1, 2024; offset by premium growth from the remaining third-party FAL business.
Gross premiums written in 2023 increased by $51.9 million or 11.5%, compared to 2022. The increase was predominantly attributable to property and specialty lines due to improved pricing and new business. This was partially offset mostly by a decrease in financial line predominantly due to lower level of activity in transactional liability business.
Net Premiums Written
Ceded premiums written in 2024 was $62.4 million, resulting in net premiums written of $541.4 million, compared to $37.9 million and $466.5 million, respectively, in 2023. The increase in ceded premiums written of 64.6% was primarily within our specialty line driven by additional retrocessional coverage to manage our overall exposure to aviation, marine and energy classes of business and to reinstate certain retrocession excess of loss treaties in which the full coverage was presumed exhausted primarily from the Baltimore Bridge loss event in 2024 and the Russian-Ukraine conflict event in 2022. Additionally, we had an increase in quota share retrocessions due to growth from inward property and M&E business.
Ceded premiums written in 2023 was $37.9 million, resulting in net premiums written of $466.5 million, compared to $14.7 million and $437.8 million, respectively, in 2022. The increase in ceded premiums written of 157.0% was predominantly attributable to an increase in quota share retrocessions due to growth from inward property business.
Net Premiums Earned
Net premiums earned by line of business were as follows:
| % Change | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2024 to 2023 | 2023 to 2022 | |||||||||||||||||||||||
| Casualty | $ | 89,213 | 17.4 | % | $ | 82,365 | 17.6 | % | $ | 78,160 | 19.0 | % | 8.3 | % | 5.4 | % | |||||||||||
| Financial | 56,903 | 11.1 | % | 56,195 | 12.0 | % | 56,952 | 13.9 | % | 1.3 | % | (1.3) | % | ||||||||||||||
| Health | 217 | — | % | 224 | — | % | 5,507 | 1.3 | % | (3.1) | % | (95.9) | % | ||||||||||||||
| Multiline | 191,849 | 37.5 | % | 205,573 | 44.0 | % | 196,974 | 47.9 | % | (6.7) | % | 4.4 | % | ||||||||||||||
| Property | 49,262 | 9.6 | % | 35,853 | 7.8 | % | 20,781 | 5.1 | % | 37.4 | % | 72.5 | % | ||||||||||||||
| Specialty | 124,477 | 24.4 | % | 86,541 | 18.6 | % | 52,503 | 12.8 | % | 43.8 | % | 64.8 | % | ||||||||||||||
| Total | $ | 511,921 | 100.0 | % | $ | 466,751 | 100.0 | % | $ | 410,877 | 100.0 | % | 9.7 | % | 13.6 | % |
Net premiums earned in 2024 increased by $45.2 million or 9.7%, compared to 2023. Further, net premiums earned in 2023 increased by $55.9 million or 13.6%, compared to 2022. The increase (decrease) in net premiums earned by line of business is relatively consistent with the trends noted for the gross premiums written. The change is also influenced by the amount and timing of net premiums written during the current year and prior years, coupled with the business mix written in the form of excess of loss versus proportional contracts. Additionally, within the financial line and certain specialty line classes, the gross premiums written are earned over multiple years, corresponding with the anticipated risk coverage period.
Loss ratio
The components of the loss ratio were as follows:
57
Return to table of contents
| Year ended December 31, | 2024 | % Point Change | 2023 | % Point Change | 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current year: | |||||||||||||||
| Attritional loss ratio | 56.8 | % | 4.6 | % | 52.2 | % | (5.0) | % | 57.2 | % | |||||
| CAT losses | 7.0 | % | 3.7 | % | 3.3 | % | (5.7) | % | 9.0 | % | |||||
| Current year loss ratio | 63.8 | % | 8.3 | % | 55.4 | % | (10.7) | % | 66.2 | % | |||||
| Prior year reserve development ratio | 2.9 | % | 2.1 | % | 0.8 | % | 1.6 | % | (0.8) | % | |||||
| Loss ratio | 66.7 | % | 10.5 | % | 56.2 | % | (9.2) | % | 65.4 | % |
Current Year Loss Ratio
The current year loss ratio in 2024 increased by 8.3%, compared to 2023 due to:
•4.6% increase in attritional loss ratio in 2024, driven mainly by higher reserve estimates for the growing in-force casualty, specialty and property lines of business.
•3.7% increase in CAT losses, net of reinsurance, primarily attributable to more severe CAT loss events in 2024 including the Baltimore Bridge collapse and Hurricanes Helene and Milton, compared to one major CAT event in 2023 (the Mexican state-owned oil platform fire loss).
The current year loss ratio in 2023 decreased by 10.7%, compared to 2022 due to:
•5.0% decrease in attritional loss ratio 2024, driven mainly by a change in business mix coupled with lower attritional loss estimates, principally on property and specialty lines of business that performed strongly; and
•5.7% decrease in CAT losses, net of reinsurance, primarily attributable to lower volume and less severe CAT loss events in 2023, compared to two major CAT events in 2022 (Hurricane Ian and the Russian-Ukrainian conflict).
Prior Year Reserve Development Ratio
Prior year reserve development ratio increased by 2.1% in 2024 compared to 2023, and by 1.6% in 2023 compared to 2022. Refer to Note 7 Loss and LAE Reserves to the consolidated financial statements for further details on the lines of business and prior year development.
Acquisition cost ratio
The acquisition cost ratio decreased to 28.3% in 2024 from 29.2% in 2023, primarily due business mix and higher ratio of excess of loss contracts at lower commission rates than quota share reinsurance contracts; partially offset by higher acquisition costs for certain 2023 and 2024 FAL business in our multiline business.
The acquisition cost ratio decreased to 29.2% in 2023 from 30.5% in 2022, primarily due to business mix and higher ratio of excess of loss contracts at lower commission rate than quota share reinsurance contracts.
Underwriting expense ratio
The underwriting expense ratio decreased marginally by 0.2% to 4.0% in 2024 compared to 2023, mainly due to an increase in net premiums earned, partially offset by an increase in personnel to support the business growth.
The underwriting expense ratio decreased marginally by 0.3% to 4.2% in 2023 compared to 2022, mainly due to lower interest expense on deposit-accounted contracts and an increase in net premiums earned. This was partially offset by an increase in personnel to support the business growth.
Income before income taxes
The income before income taxes for Open Market decreased by $38.2 million to $47.7 million in 2024 compared to 2023, driven predominantly by lower underwriting profits; partially offset by an increase in investment income on funds withheld by third party Lloyd’s syndicates.
58
Return to table of contents
The income before income taxes for Open Market increased by $82.7 million to $85.9 million in 2023 compared to 2022, driven by strong underwriting profits; coupled with an increase in investment income driven mostly by favorable interest rate environment.
Innovations Segment
Results for the Innovations segment were as follows:
| Year ended December 31, | 2024 | % Change | 2023 | % Change | 2022 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross premiums written | $ | 94,725 | 6.9 | % | $ | 88,602 | 74.6 | % | $ | 50,739 | |||||||
| Net premiums written | $ | 80,016 | (4.3) | % | $ | 83,608 | 76.7 | % | $ | 47,328 | |||||||
| Net premiums earned | $ | 86,352 | 20.3 | % | $ | 71,769 | 116.3 | % | $ | 33,184 | |||||||
| Net loss and LAE incurred | (51,939) | (44,855) | (23,151) | ||||||||||||||
| Acquisition costs | (27,151) | (22,381) | (11,111) | ||||||||||||||
| Other underwriting expenses | (3,682) | (2,760) | (1,946) | ||||||||||||||
| Underwriting income (loss) | 3,580 | 1,773 | (3,024) | ||||||||||||||
| Net investment income | 702 | (74.3) | % | 2,732 | (72.3) | % | 9,869 | ||||||||||
| Corporate and other expenses | (2,445) | (20.6) | % | (3,080) | (10.8) | % | (3,452) | ||||||||||
| Income before income taxes | $ | 1,837 | $ | 1,425 | $ | 3,393 | |||||||||||
| Underwriting ratios: | 2024 | % Point Change | 2023 | % Point Change | 2022 | ||||||||||||
| Loss ratio | 60.1 | % | (2.4) | % | 62.5 | % | (7.3) | % | 69.8 | % | |||||||
| Acquisition cost ratio | 31.4 | % | 0.2 | % | 31.2 | % | (2.3) | % | 33.5 | % | |||||||
| Composite ratio | 91.5 | % | (2.2) | % | 93.7 | % | (9.6) | % | 103.3 | % | |||||||
| Underwriting expenses ratio | 4.3 | % | 0.5 | % | 3.8 | % | (2.1) | % | 5.9 | % | |||||||
| Combined ratio | 95.8 | % | (1.7) | % | 97.5 | % | (11.7) | % | 109.2 | % |
Gross Premiums Written
Gross premiums written by line of business were as follows:
| % Change | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2024 to 2023 | 2023 to 2022 | |||||||||||||||||||||||
| Casualty | $ | 24,843 | 26.2 | % | $ | 19,447 | 21.9 | % | $ | 5,653 | 11.1 | % | 27.7 | % | 244.0 | % | |||||||||||
| Financial | 7,800 | 8.2 | % | 6,955 | 7.8 | % | 2,617 | 5.2 | % | 12.1 | % | 165.8 | % | ||||||||||||||
| Health | 4,631 | 4.9 | % | 3,998 | 4.5 | % | 7,201 | 14.2 | % | 15.8 | % | (44.5) | % | ||||||||||||||
| Multiline | 47,311 | 49.9 | % | 50,490 | 57.0 | % | 30,816 | 60.7 | % | (6.3) | % | 63.8 | % | ||||||||||||||
| Specialty | 10,140 | 10.8 | % | 7,712 | 8.8 | % | 4,452 | 8.8 | % | 31.5 | % | 73.2 | % | ||||||||||||||
| Total | $ | 94,725 | 100.0 | % | $ | 88,602 | 100.0 | % | $ | 50,739 | 100.0 | % | 6.9 | % | 74.6 | % |
Gross premiums written in 2024 increased by $6.1 million or 6.9%, compared to 2023. The increase was predominantly attributable to: (i) growth from existing customers in the casualty line and (ii) new customers in our financial, health, multiline (new accounts in our Syndicate 3456) and specialty lines. This was partially offset by a non-renewed treaty and lower premium volume from certain existing customers in our multiline business.
Gross premiums written in 2023 increased by $37.9 million or 74.6%, compared to 2022. The increase was predominantly attributable to the casualty line driven by new business and accelerated growth with existing customers, coupled with growth in our multiline driven by new business from our Syndicate 3456. This was partially offset by a decrease in health line predominantly due to the non-renewal of a program.
59
Return to table of contents
Net Premiums Written
Ceded premiums written in 2024 was $14.7 million, resulting in net premiums written of $80.0 million, compared to $5.0 million and $83.6 million, respectively, in 2023. The increase in ceded premiums written of 194.5% was predominantly in the casualty line and, to a lesser extent, in the multiline and specialty lines driven by quota share reinsurance treaties with our assumed customers in which they share indirectly the underwriting risks through their captives or other platforms.
Ceded premiums written in 2023 was $5.0 million, resulting in net premiums written of $83.6 million, compared to $3.4 million and $47.3 million, respectively, in 2022. The increase in ceded premiums written was predominantly in the multiline business due to new assumed business.
Net Premiums Earned
Net premiums earned by line of business were as follows:
| % Change | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2024 to 2023 | 2023 to 2022 | |||||||||||||||||||||||
| Casualty | $ | 18,705 | 21.7 | % | $ | 13,332 | 18.6 | % | $ | 3,890 | 11.7 | % | 40.3 | % | 242.7 | % | |||||||||||
| Financial | 5,499 | 6.4 | % | 5,076 | 7.1 | % | 655 | 2.0 | % | 8.3 | % | 675.0 | % | ||||||||||||||
| Health | 2,144 | 2.5 | % | 2,522 | 3.5 | % | 7,030 | 21.2 | % | (15.0) | % | (64.1) | % | ||||||||||||||
| Multiline | 51,669 | 59.8 | % | 44,533 | 62.1 | % | 19,080 | 57.5 | % | 16.0 | % | 133.4 | % | ||||||||||||||
| Specialty | 8,335 | 9.6 | % | 6,306 | 8.7 | % | 2,529 | 7.6 | % | 32.2 | % | 149.3 | % | ||||||||||||||
| Total | $ | 86,352 | 100.0 | % | $ | 71,769 | 100.0 | % | $ | 33,184 | 100.0 | % | 20.3 | % | 116.3 | % |
Net premiums earned in 2024 increased by $14.6 million or 20.3%, compared to 2023. Further, net premiums earned in 2023 increased by $38.6 million or 116.3%, compared to 2022. The increase in net premiums by line of business is relatively consistent with the trends noted for the gross premiums written. The change is also influenced by the amount and timing of net premiums written during the current year and prior years, coupled with the business mix written in the form of excess of loss versus proportional contracts.
Loss ratio
The components of the loss ratio were as follows:
| Year ended December 31, | 2024 | % Point Change | 2023 | % Point Change | 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current year: | |||||||||||||||
| Attritional loss ratio | 60.5 | % | (1.4) | % | 61.9 | % | 0.2 | % | 61.7 | % | |||||
| CAT losses | — | % | — | % | — | % | — | % | — | % | |||||
| Current year loss ratio | 60.5 | % | (1.4) | % | 61.9 | % | 0.2 | % | 61.7 | % | |||||
| Prior year reserve development ratio | (0.3) | % | (0.9) | % | 0.6 | % | (7.4) | % | 8.0 | % | |||||
| Loss ratio | 60.1 | % | (2.4) | % | 62.5 | % | (7.3) | % | 69.8 | % |
Current Year Loss Ratio
The current year loss ratio in 2024 decreased by 1.4%, compared to 2023 driven mainly by modest lower attritional loss ratio in our casualty, multiline and specialty lines due to new business; offset predominantly by a 2023 quota share reinsurance program in financial lines, which we did not renew but continued to earn premiums in 2024.
The current year loss ratio in 2023 increased marginally by 0.2%, compared to 2022.
The Innovations segment was not impacted by any CAT events for the years presented in the above table.
60
Return to table of contents
Prior Year Reserve Development Ratio
Prior year reserve development ratio improved by 0.9% in 2024 compared to 2023, and by 7.4% in 2023 compared to 2022. Refer to Note 7 Loss and LAE Reserves to the consolidated financial statements for further details on the lines of business and prior year development.
Acquisition cost ratio
The acquisition cost ratio increased marginally by 0.2% to 31.4% in 2024 compared to 2023.We had lower acquisition costs predominantly from the financial line due to lower profit commission relating to a non-renewed program; offset mainly by new accounts in the multiline business, within our Syndicate 3456, at higher acquisition costs.
The acquisition cost ratio decreased by 2.3% to 31.2% in 2023 compared to 2022, primarily due to growth in net premiums earned from our Syndicate 3456 (included in multiline) to cover fixed acquisition costs, coupled with a change in business mix with growth in our casualty and specialty lines due to new accounts at lower acquisition costs.
Underwriting expense ratio
The underwriting expense ratio increased by 0.5% to 4.3% in 2024 compared to 2023, mainly due to an increase in personnel and overhead costs to support the Innovations business growth; partially offset by the 20.3% increase in net premiums earned to cover fixed costs.
The underwriting expense ratio decreased by 2.1% to 3.8% in 2023 compared to 2022, mainly due to the 116.3% increase in net premiums earned to cover fixed costs, partially offset by an increase in personnel costs to support the Innovations business growth.
Income before income taxes
The income before income taxes for Innovations was $1.8 million in 2024 compared to $1.4 million in 2023. The increase was mainly due to an increase in underwriting income, partially offset by lower net investment income driven by net downward valuation adjustments relating to certain Innovations private investments.
The income before income taxes for Innovations was $1.4 million in 2023 compared to $3.4 million in 2022. The decrease was driven by a decrease in net investment income mainly due to lower unrealized gains from our Innovations private investments, in part due to less favorable pricing conditions from financing rounds completed by our investees. This was partially offset by improved underwriting performance and lower Innovations-related expenses.
Other Corporate
Runoff Underwriting Business
In late 2023, we made the decision to not renew a property business due to significant CAT losses relating to unprecedented severe convective storms in the U.S. On the quota share reinsurance treaty bound in 2023, we continued to earn premiums in 2024 and incurred additional CAT losses from severe convective storms that occurred in 2024. For the years ended December 31, 2024, 2023, and 2022, we incurred an underwriting loss of $16.8 million, $18.4 million, and $6.0 million, respectively, including prior year adverse development of $6.2 million, $7.2 million, and $0.9 million, respectively. This was partially offset by investment income of $1.4 million, $2.3 million, and $0.1 million, respectively, relating to this runoff business.
We have reported the results of the above property runoff business as part of Corporate in Note 17 Segment Reporting in the consolidated financial statements.
Income from Investment in Solasglas
Our share of Solasglas’ net income increased by $4.9 million to $33.6 million in 2024 compared to 2023. For the year ended December 31, 2024, Solasglas reported a net investment return of 9.8%, compared to 9.4% for 2023. The following table provides a breakdown of the gross and net investment return for Solasglas:
61
Return to table of contents
| 2024 | 2023 | ||||
|---|---|---|---|---|---|
| Long portfolio gains (losses) | 10.3 | % | 32.1 | % | |
| Short portfolio gains (losses) | (2.3) | (22.1) | |||
| Macro gains (losses) | 4.4 | 3.7 | |||
| Other income and expenses 1 | (1.6) | (3.2) | |||
| Gross investment return | 10.8 | % | 10.5 | % | |
| Net investment return 1 | 9.8 | % | 9.4 | % |
1 “Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporates both of these amounts. For further information about management fees and performance compensation, refer to Note 15 “Related Party Transactions” of the consolidated financial statements.
For the year ended December 31, 2024, the significant contributors to Solasglas’ investment return were long positions in gold, Kyndryl Holdings (KD) and GRBK. The largest detractors were three single-name short positions.
For the year ended December 31, 2023, the significant contributors to Solasglas’ investment return were long positions in GRBK, CONSOL Energy Inc., and a S&P 500 / U.S. interest rate derivative position. The most significant detractors were three single-name short positions.
Each month, we post on our website (www.greenlightre.com) the returns from our investment in Solasglas.
Financial Condition
Investments
The following table provides a breakdown of our total investments:
| At December 31, | 2024 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment in related party investment fund (Solasglas) | $ | 387,144 | 84.1 | % | $ | 258,890 | 78.0 | % | ||||||
| Other investments: | ||||||||||||||
| Private investments and unlisted equities | 71,867 | 15.6 | 71,157 | 21.4 | ||||||||||
| Debt and convertible debt securities | 1,293 | 0.3 | 2,136 | 0.6 | ||||||||||
| Total other investments | $ | 73,160 | 15.9 | % | $ | 73,293 | 22.0 | % | ||||||
| Total investments | $ | 460,304 | 100.0 | % | $ | 332,183 | 100.0 | % |
At December 31, 2024, our total investments increased by $128.1 million, or 38.6%, to $460.3 million from December 31, 2023. The increase was predominantly driven by $94.6 million of net contributions into Solasglas, coupled with the 9.8% net investment return in 2024. The contributions were funded partially from cash flows from operations and from the partial release of restricted cash.
Investments in Solasglas
DME Advisors reports the composition of Solasglas’ portfolio on a delta-adjusted basis, which it believes is the appropriate manner to assess the exposure and profile of investments and reflects how it manages the portfolio. An option’s delta is the option price’s sensitivity to the underlying stock (or commodity) price. The delta-adjusted basis is the number of shares or contracts underlying the option multiplied by the delta and the underlying stock (or commodity) price.
62
Return to table of contents
The following table represents the composition of Solasglas’ investments:
| At December 31, | 2024 | 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long % | Short % | Long % | Short % | |||||||||
| Equities and related derivatives | 73.9 | (43.3) | 90.2 | (53.8) | ||||||||
| Private and unlisted equity securities | 2.1 | — | 2.0 | — | ||||||||
| Debt instruments | 0.1 | — | 0.3 | — | ||||||||
| Total | 76.1 | % | (43.3) | % | 92.5 | % | (53.8) | % |
The above exposure analysis does not include cash (U.S. dollar and foreign currencies), gold and other commodities, credit default swaps, sovereign debt, foreign currency derivatives, interest rate derivatives, inflation swaps and other macro positions. Under this methodology, a total return swap’s exposure is reported at its full notional amount and options are reported at their delta-adjusted basis. At December 31, 2024, Solasglas’ exposure to gold on a delta-adjusted basis was 10.1% (2023: 11.2%).
At December 31, 2024, 94.5% of Solasglas’ portfolio was valued based on quoted prices in actively traded markets (Level 1), 3.9% was composed of instruments valued based on observable inputs other than quoted prices (Level 2), and no instruments valued based on non-observable inputs (Level 3). At December 31, 2024, 1.6% of Solasglas’ portfolio consisted of private equity funds valued using the funds’ net asset values as a practical expedient.
Other Investments
The other investment holdings relate to private investments made by Innovations. At December 31, 2024, total other investments decreased marginally since December 31, 2023. During 2024 we made $1.7 million of new private investments compared to $7.1 million in the prior year. The increase in private investments was offset by $0.9 million of proceeds from a partial sale of one our holdings, coupled with net unfavorable change in fair value.
While we manage a diversified Innovations-related investment portfolio, our top five holdings accounted for 70% (2023: 67%) of the total carrying value. For further information, see Note 4 “Other Investments” of the consolidated financial statements.
Restricted cash and cash equivalents
We use our restricted cash and cash equivalents primarily for funding trusts and letters of credit issued to our ceding insurers. Our restricted cash decreased by $20.2 million, or 3.3%, from $604.6 million at December 31, 2023, to $584.4 million at December 31, 2024, primarily due to release of collateral from our ceding insurers relating to legacy contracts in runoff.
Reinsurance balances receivable
Our reinsurance balances receivable increased by $85.1 million, or 13.7%, to $704.5 million from $619.4 million at December 31, 2023. This was driven primarily by $66.7 million increase in premiums receivable, net of collections, and $19.6 million in funds withheld from new and renewed reinsurance treaties.
Loss and LAE Reserves; Loss and LAE Recoverable
Our total gross loss and LAE reserves increased by $199.4 million, or 30.1%, to $861.0 million from $661.6 million at December 31, 2023. See Note 7 “Loss and Loss Adjustment Expense Reserves” of the consolidated financial statements for a summary of changes in outstanding loss and LAE reserves, current year CAT losses, prior period reserve development, and analysis of our incurred and paid claims development and claims duration for each of our reporting segments. In addition, refer to “Critical Accounting Estimates - Loss and LAE Reserves” within this MD&A for information on the reserving techniques, assumptions and processes we follow to estimate our loss and LAE reserves.
Our total loss and LAE recoverable increased by $60.1 million, or 234.0%, to $85.8 million since December 31, 2023, driven primarily by retrocession coverage on the current year CAT loss events and on the adverse reserve development relating to the Russian-Ukrainian conflict. Virtually all the outstanding balance is based on estimated recoveries not yet due. See Note 8 “Retrocession” of the consolidated financial statements for a description of the credit risk associated with our retrocessionaires.
63
Return to table of contents
Catastrophe Loss Exposure
Most of our contracts have defined limits of liability that cap our risk exposure. Once these limits are reached, we are not liable for further losses. However, some contracts, especially quota share contracts covering first-dollar exposure, lack aggregate limits.
Our property and Lloyd’s business, and to a lesser extent our casualty and other business, in the Open Market segment include contracts with natural peril loss exposure. We monitor our catastrophe loss exposure using PML (net of retrocession and reinstatement premiums), which can vary based on simulated losses and our in-force business composition.
We track natural peril PMLs globally, focusing on peak peril regions and subdividing large geographic areas into individual peril zones. For natural catastrophe PMLs, we use catastrophe models at the 1-in-250-year return period, indicating a 0.4% probability of exceeding the estimated losses in any given year.
PMLs are best estimates based on available modeled data, and actual events may differ significantly from these models. Our PML estimates cover all significant exposures from our reinsurance operations, including property, marine and energy, motor, and catastrophe workers’ compensation.
At January 1, 2025, our estimated largest PML at a 1-in-250-year return period for a single event and in aggregate was $116.3 million and $129.1 million, respectively, both relating to the peril of North Atlantic Hurricane, compared to $89.7 million and $97.0 million, respectively, at January 1, 2024. Our PMLs increased as we grew our clients and accessed new business that met our profitability requirements.
The below table contains the expected modeled loss for each of our peak peril regions and sub-regions for both a single event loss and aggregate loss measures at the 1-in-250-year return period.
| January 1, 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Net 1-in-250 Year Return Period | |||||||
| Peril | Single Event Loss | Aggregate Loss | |||||
| North Atlantic Hurricane | $ | 116,309 | $ | 129,144 | |||
| Southeast Hurricane | 99,968 | 99,968 | |||||
| Gulf of Mexico Hurricane | 53,724 | 53,841 | |||||
| Northeast Hurricane | 58,973 | 58,973 | |||||
| North America Earthquake | 111,446 | 113,280 | |||||
| California Earthquake | 97,033 | 97,644 | |||||
| Pacific Northwest Earthquake | 45,101 | 45,101 | |||||
| Other N.A. Earthquake | 43,163 | 43,278 | |||||
| Japan Earthquake | 34,133 | 34,664 | |||||
| Japan Windstorm | 23,198 | 24,421 | |||||
| Europe Windstorm | 63,075 | 67,628 |
Liquidity and Capital Resources
Liquidity
Liquidity is a measure of a company’s ability to generate sufficient cash flows to meet the short-term and long-term cash requirements of its business operations. We manage liquidity at the holding company and operating subsidiary level.
Holding Company
Greenlight Capital Re is a holding company with no operations of its own and its assets consist primarily of investments in its subsidiaries. Accordingly, Greenlight Capital Re’s future cash flows depend on the availability of dividends or other statutorily permissible distributions, such as returns of capital, from its subsidiaries. The ability to pay dividends and/or distributions is limited by:
•the applicable laws and regulations of the countries in which Greenlight Capital Re’s subsidiaries operate (see Note 18 “Statutory Requirements” to the consolidated financial statements);
•the need to maintain adequate capital levels to support our reinsurance operations; and
64
Return to table of contents
•the need to preserve our current “A- (Excellent)” rating by A.M. Best.
As a holding company, Greenlight Capital Re has minimal continuing cash needs, most of which are related to the payment of corporate and general administrative expenses and interest expenses. Our current policy is to retain earnings to support the growth of our business. We currently do not expect to pay dividends on our ordinary shares.
We anticipate positive cash flows from operations (underwriting activities and investment income) to be sufficient to cover cash outflows under most loss scenarios in the near term. Based on expected cash flows from operations, financing arrangements and redemptions from related party investment fund as needed (subject to three day’s notice to the general partner), we believe we have sufficient liquidity to cover our working capital requirements and other contractual obligations and commitments through the foreseeable future.
Operating Subsidiaries
Our sources of funds from operating subsidiaries consist primarily of premium receipts (net of brokerage and ceding commissions), investment income, and other income. We use cash from our operations to pay losses and loss adjustment expenses, profit commissions, interest, and G&A expenses. Our reinsurance business inherently provides liquidity as premiums are received in advance of the time claims are paid. However, the amount of cash required to fund loss payments can fluctuate significantly from period to period due to the low frequency / high severity nature of certain types of business we write.
The following table summarizes our sources and uses of funds:
| 2024 | 2023 | |||||
|---|---|---|---|---|---|---|
| Total cash provided by (used in): | ||||||
| Operating activities | $ | 111,504 | $ | 7,507 | ||
| Investing activities | (96,562) | (53,133) | ||||
| Financing activities | (21,240) | (5,292) | ||||
| Effect of currency exchange on cash(1) | (345) | 100 | ||||
| Net cash inflows (outflows) | (6,643) | (50,818) | ||||
| Cash, beginning of period | 655,730 | 706,548 | ||||
| Cash, end of period | $ | 649,087 | $ | 655,730 |
(1) Cash includes unrestricted and restricted cash and cash equivalents - see Note 5 “Restricted Cash and Cash Equivalents” of the consolidated financial statements.
Cash provided by operating activities
The $104.0 million increase in cash provided by operating activities was driven mainly by the ebb and flow from our underwriting activities. Cash inflows from underwriting activities generally include premiums, net of acquisition costs, and reinsurance recoverables. Cash outflows principally include payments of losses and LAE, payments of retrocession premiums, and operating expenses. Cash provided by operating activities may vary significantly from period to period due to the timing of these inflows and outflows.
Cash used in investing activities
The $43.4 million increase in cash used for investing activities was driven predominantly by an increase in the net contribution to Solasglas.
Cash used in financing activities
Financing cash outflows in 2024 were driven mainly by the $7.5 million of share repurchases and $13.8 million of debt repayments.
Financing cash outflows in 2023 were driven by the $17.2 million repurchase of convertible senior notes; partially offset by the net proceeds from the debt refinancing where we issued $75.0 million of Term Loans to repay the remaining $62.1 million convertible senior notes.
Capital Resources
The following table summarizes our debt and capital structure:
65
Return to table of contents
| 2024 | 2023 | ||||||
|---|---|---|---|---|---|---|---|
| Debt - outstanding principal | $ | 60,313 | $ | 74,062 | |||
| Shareholders’ equity | 635,879 | 596,095 | |||||
| Total capital | $ | 696,192 | $ | 670,157 | |||
| Ratio of debt to shareholders’ equity | 9.5 | % | 12.4 | % |
The debt to shareholders’ equity provides an indication of our leverage and capital structure, along with some insights into our financial strength. In addition to the above capital, we also have LOC facilities to support our reinsurance business operations where we are not licensed or admitted as a reinsurer (see Note 9 “Debt and Credit Facilities” of the consolidated financial statements for further information).
Debt
As a result of a $10.0 million voluntary repayment and regular quarterly installments, our total debt (including accrued interest) decreased by $12.5 million, or 17.1%, to $60.7 million at the end of December 31, 2024, down from $73.3 million on December 31, 2023.
Total shareholders’ equity
Total shareholders’ equity increased by $39.8 million to $635.9 million, compared to $596.1 million at December 31, 2023. The increase was primarily due to the net income of $42.8 million reported for the year, coupled with share-based compensation adjustment to additional paid-in capital. This was partially offset by $7.5 million of share repurchases in the open market at an average price of $13.68 per share.
At December 31, 2024, there were 34,831,324 outstanding ordinary shares, a decrease of 505,408 since December 31, 2023, mainly due to 547,402 of share repurchases offset partially by issuance of restricted shares and ordinary shares for vested RSUs, net of forfeitures.
We expect that the existing capital base and internally generated funds will be sufficient to implement our business strategy for the foreseeable future. However, to provide us with flexibility and timely access to public capital markets should we require additional capital for working capital, capital expenditures, acquisitions, or other general corporate purposes, we have renewed our $200.0 million shelf registration by filing the Form S-3 registration statement with the SEC, which became effective on July 5, 2024, and will expire on July 1, 2027.
Contractual Obligations and Commitments
At December 31, 2024, our contractual obligations and commitments by period due were as follows:
| Less than 1 year | 1-3 years | 3-5 years | More than 5 years | Total | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||||||||
| Loss and loss adjustment expense reserves (1) | $ | 338,361 | $ | 297,034 | $ | 105,899 | $ | 119,675 | $ | 860,969 | ||||||||
| Operating lease obligations (2) | 686 | 377 | — | — | 1,063 | |||||||||||||
| Financing activities | ||||||||||||||||||
| Debt (principal payments) (3) | 3,016 | 57,297 | — | — | 60,313 | |||||||||||||
| Total | $ | 342,062 | $ | 354,708 | $ | 105,899 | $ | 119,675 | $ | 922,345 |
(1) Due to the nature of our reinsurance operations, the actual amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain. We have not taken into account corresponding reinsurance recoverable on unpaid amounts that would be due to us.
(2) See Note 16 “Commitments and Contingencies” of the consolidated financial statements.
(3) See Note 9 “Debt and Credit Facilities” of the consolidated financial statements.
66
Return to table of contents
Critical Accounting Estimates
Our consolidated financial statements contain certain amounts that are inherently subjective and have required management to make assumptions and best estimates to determine reported values. If certain factors, including those described in “Part I, Item IA. — Risk Factors,” cause actual events or results to differ materially from our underlying assumptions or estimates. In that case, there could be a material adverse effect on our results of operations, financial condition, or liquidity.
We believe the following are the critical accounting estimates used to prepare our consolidated financial statements:
•Premium recognition
•Loss and LAE reserves
•Investments valuation
The following provides a summary of our accounting policies for the above critical accounting estimates.
Premium Recognition
Gross Premiums Written
We record our property and casualty reinsurance premiums as premiums written based on our best estimate of the ultimate premiums for the contract period. Our estimates are based on actuarial pricing models, information received from ceding companies, and from Lloyd’s syndicates (for FAL business). Further, we record reinsurance premiums so long as they meet the risk transfer criteria under U.S. GAAP (see “Deposit Contracts” below).
The recognition of gross premiums written will vary based on the type of the reinsurance contract as follows:
•Excess of loss contracts: typically the contracts state premiums as a percentage of the subject premiums written by the client, subject to a minimum and deposit premium. The minimum and deposit premium is generally based on an estimate of subject premiums expected to be written by the client during the contract term. At the inception of the contract, we record the total contractual minimum and deposit premium, which is subsequently adjusted when the actual subject premium is known. Generally, the adjustment to actual is not material on an aggregate basis.
•Quota share (also known as proportional) contracts: we record our participation share of the estimated ultimate premiums in the same periods in which the underlying insurance contracts are written. For example, for a 12-month quota share reinsurance contract, we will recognize the estimated gross premiums written over 12 months, generally on a linear basis.
•For multi-year contracts: we record reinsurance premiums at the inception of the contract based on our best estimate of total premiums to be received. Premiums are recognized on an annual basis for multi-year contracts where the cedants have the ability to unilaterally commute or cancel coverage within the term of the contract.
We write mostly quota share reinsurance treaties. The following table provides a summary of our estimated gross premiums written for quota share reinsurance contracts incepting during the year:
| 2024 | 2023 | 2022 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Open Market segment | $ | 402,666 | $ | 358,230 | $ | 350,595 | ||||
| Innovations segment | 45,494 | 44,133 | 33,030 | |||||||
| Property runoff | — | 42,744 | 54,511 | |||||||
| Total quota share estimated premiums | 448,160 | 445,107 | 438,136 | |||||||
| Consolidated gross premiums written | 698,335 | 636,810 | 563,171 | |||||||
| As of % of total consolidated | 64 | % | 70 | % | 78 | % |
We regularly review premium estimates. Such review includes our experience with the ceding companies, managing general underwriters, familiarity with each market, the timing of the reported information, a comparison of reported premiums to
67
Return to table of contents
expected ultimate premiums, along with a review of the aging and collection of premiums. We evaluate the appropriateness of the premium estimates on the basis of these reviews and record any adjustments to these estimates in the period in which they are determined. Changes in premium estimates, including premium receivable on both excess of loss and quota share contracts, are not unusual and may result in significant adjustments in any period. A portion of amounts included in “Reinsurance balances receivable” in the consolidated balance sheets represent estimated premiums written, net of commissions and brokerage, that are not currently due based on the terms of the underlying contracts. Additional premiums due on a contract with no remaining coverage period are earned in full when written.
Certain contracts provide for reinstatement premiums in the event of a loss. Reinstatement premiums are written and earned when a triggering loss event occurs, based on management’s estimates of the ultimate reinstatement premiums. These estimates are subsequently adjusted when actual reinstatement premiums are known.
Net Premiums Earned
We earn premiums over the risk coverage period. Unearned premiums represent the unexpired portion of reinsurance provided. Changes in circumstances subsequent to the inception of contracts can impact the earnings period. For instance, when exposure limits for a reinsurance contract are reached, any associated unearned premiums are fully earned.
Excess of loss reinsurance contracts are generally written on a “losses occurring” or “claims made” basis over the term of the policy. Accordingly, premiums are earned evenly over the contract term, which is generally 12 months.
Line slip or proportional insurance/reinsurance contracts are generally written on a “risks attaching” basis, covering claims that relate to the underlying policies written during the terms of these contracts. As the underlying business incepts throughout the contract term, which is generally one year, and the underlying business generally has a one year coverage period, these premiums are generally earned evenly over a 24-month period from inception. For certain classes within financial and specialty lines of business, the underlying risk exposure period extend over several years and accordingly these premiums are earned over up to 60-months.
Deposit Contracts
If we determine that a reinsurance contract does not transfer sufficient risk to merit reinsurance accounting treatment, we report the premium we receive as a deposit liability. Similarly, we report the premium we pay as a deposit asset for ceded contracts that do not transfer sufficient risk to merit reinsurance accounting. Any income and expense on deposit-accounted contracts is calculated using the interest method and recorded in the consolidated statements of operations under “Other income (expense)” and “Deposit interest expense,” respectively.
Loss and LAE Reserves
Estimating our loss and LAE reserves involves a considerable degree of judgment, and our estimates as of any given date are inherently uncertain. Estimating loss and LAE reserves requires us to make assumptions regarding reporting and development patterns, frequency and severity trends, claims settlement practices, potential changes in legal environments, inflation, loss amplification, foreign exchange movements, and other factors. These estimates and judgments are based on numerous considerations and are often revised as (i) we receive changes in loss amounts reported by ceding companies and brokers; (ii) we obtain additional information, experience, or other data; (iii) we develop new or improved methodologies; or (iv) we observe changes in the legal environment.
Our loss and LAE reserves relating to short-tail property risks are typically reported to us and settled more promptly than those relating to long-tail risks. However, the timeliness of loss reporting can be affected by such factors as the nature of the event causing the loss, the location of the loss, whether the loss is from policies in force with primary insurers or with reinsurers, and where our exposure falls within the cedent’s overall reinsurance program.
Our loss and LAE reserves are composed of case reserves (based on claims reported to us) and IBNR reserves, including the associated claims handling costs. The following table summarizes our gross reserves for loss and LAE for each of the reportable segments, by line of business, and the runoff business at December 31, 2024:
68
Return to table of contents
| Case reserves | IBNR | Total loss and LAE reserves | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Open Market segment: | |||||||||||
| Casualty | $ | 72,547 | $ | 127,268 | $ | 199,815 | |||||
| Financial | 25,088 | 38,167 | 63,255 | ||||||||
| Health | 3 | 176 | 179 | ||||||||
| Multiline | 51,735 | 145,638 | 197,373 | ||||||||
| Property | 39,623 | 55,119 | 94,742 | ||||||||
| Specialty | 22,129 | 192,282 | 214,411 | ||||||||
| Total Open Market segment | 211,125 | 558,650 | 769,775 | ||||||||
| Innovations segment: | |||||||||||
| Casualty | 672 | 21,587 | 22,259 | ||||||||
| Financial | 876 | 3,048 | 3,924 | ||||||||
| Health | 399 | 995 | 1,394 | ||||||||
| Multiline | 11,963 | 34,697 | 46,660 | ||||||||
| Specialty | 972 | 1,776 | 2,748 | ||||||||
| Total Innovations segment | 14,882 | 62,103 | 76,985 | ||||||||
| Corporate (property business in runoff) | 4,626 | 9,583 | 14,209 | ||||||||
| Total | $ | 230,633 | $ | 630,336 | $ | 860,969 | |||||
| % of total | 27 | % | 73 | % | 100 | % |
We determine case reserve estimates based on loss reports received. We determine our IBNR reserve estimates using standard actuarial methods and a combination of our own historical and current loss experience, insurance industry loss experience, assessments of pricing adequacy trends, and our professional judgment. In estimating our IBNR reserve, we estimate the total ultimate loss and LAE we expect to incur and subtract paid claims and case reserves.
The nature and extent of our judgment in the reserving process depend in part upon the type of business. Some of our property treaty reinsurance contracts represent business with a low frequency of claims occurrence and a high potential loss severity, such as claims arising from natural catastrophes. Given the nature of these events, traditional actuarial reserving methods may not be reliable indicators of the final outcome. As such, for contracts or losses of this type, we estimate the ultimate cost associated with a single loss event rather than perform analysis on the historical development patterns of past events to estimate the ultimate losses for an entire accident year. We estimate our reserves for these large events on a by-contract basis by reviewing policies with known or potential exposure to a particular loss event.
For non-catastrophe losses, we apply standard actuarial methodologies in setting reserves, including paid and incurred loss development, Bornheutter-Ferguson, burning cost, and frequency and severity techniques. We supplement our analysis with industry loss ratio and development pattern information in conjunction with our own experience. The weight given to a particular method will depend on many factors, including the homogeneity within the class of business, the volume of losses, the maturity of the accident year, and the length of the expected development tail. For example, the expected loss ratio method assumes that the ratio of premiums and losses remains constant. In contrast, development methods rely on observable patterns within reported losses, both historical and newly reported, to establish a view of the ultimate loss incurred. Therefore, as an accident year matures, we may migrate from an expected loss ratio method to an incurred development method.
As a predominantly broker-market reinsurer for both excess-of-loss and proportional contracts, we rely on loss information reported to brokers by primary insurers who, in turn, must estimate their losses at the policy level, often based on incomplete and changing information. The information we receive varies by cedent and may include paid losses, estimated case reserves, and an estimated provision for IBNR reserves. Reserving practices and data-reporting quality differ among ceding companies, which adds further uncertainty to our estimation of ultimate losses. The nature and extent of information received from ceding companies and brokers also vary widely depending on the type of coverage, the contractual reporting terms (which are affected by market conditions and practices), and other factors. Due to the lack of standardization of the terms and conditions of reinsurance contracts, the differences in coverage provided to individual clients, and the tendency of those coverages to change rapidly in response to market conditions, we cannot always reliably measure the ongoing economic impact of such uncertainties and inconsistencies.
69
Return to table of contents
Time lags are inherent in loss reporting, especially in the case of excess-of-loss reinsurance contracts. The time lags, coupled with the combined characteristics of low claim frequency and high claim severity on such contracts, make the available data less useful for predicting ultimate losses.
In the case of proportional contracts, we rely on an analysis of a cedent’s historical experience, industry information, and the underwriters’ professional judgment in estimating reserves. We also utilize ultimate loss ratio forecasts when reported by cedents and brokers, which are ordinarily subject to three to six-month lags for proportional business. Due to our reliance on ceding companies for claims reporting, our reserve estimates are highly dependent on ceding companies’ judgment. Furthermore, during the loss settlement period, which may last several years, additional facts regarding individual claims and trends will often become known, and case law may change, affecting ultimate expected losses.
Since we rely on ceding company data in establishing our loss and LAE reserves, we maintain procedures designed to mitigate the risk that such information is incomplete or inaccurate. These procedures include: (i) comparisons of expected premiums to reported premiums, which helps us to identify delinquent client periodic reports; (ii) ceding company audits to identify inaccurate or incomplete reporting of claims and ensure that claims are actively and appropriately managed in line with agreed protocols and settlement authority limits; and (iii) underwriting reviews to ascertain that the losses ceded are covered as provided under the contract terms. These procedures are incorporated in our internal controls and are regularly evaluated and amended as market conditions, risk factors, and unanticipated areas of exposure develop.
We engage an independent third-party actuarial firm to perform a quarterly reserve review and annually opine on the reasonableness and adequacy of the aggregate loss reserves. We provide the third-party actuarial firm with our pricing models, reserving analysis, and other data. The actuarial firm may also inquire about the various assumptions and estimates used in the reserving analysis. The actuarial firm independently creates its own reserving models based on industry loss information, augmented by client-specific loss information and independent assumptions and estimates. Based on various reserving methodologies that the actuarial firm considers appropriate, it creates a loss reserve estimate for each segment in the portfolio. It recommends an aggregate loss reserve, including IBNR. In the event of material differences between our aggregated booked reserves and the actuarial firm's recommended reserves, the reserving committee would be notified, with the reserves adjusted as deemed appropriate. To date, there have been no material differences resulting from the external actuary’s reviews requiring adjustments to our booked reserves.
We monitor the development of our prior-year losses during subsequent calendar years by comparing the actual reported losses against previous estimates and current expectations. The analysis of this loss development is important to the ongoing refinement of our reserving assumptions. Each additional year of loss experience with a given cedent provides additional insight into the accuracy and timeliness of previously reported information.
Estimating loss reserves for our book of longer-tail casualty reinsurance business, which we write on both a proportional and non-proportional basis, involves further uncertainties. In addition to the uncertainties described above, casualty business is generally subject to longer reporting lags than property business, and claims often take several years to settle. During this period, additional factors and trends will be revealed, and we may adjust our reserves accordingly. Therefore, any factors that extend the time until our cedents settle claims add uncertainty to the reserving process.
The uncertainties inherent in the reserving process and the potential for unforeseen developments, including changes in laws and the prevailing interpretation of policy terms, may result in our loss and LAE reserves being materially greater or less than the loss and LAE reserves we initially established. We reflect adjustments to our loss and LAE reserves in our financial results during the period they are determined. Changes to our prior year loss reserves will impact our current underwriting results by improving our results if the prior year reserves prove redundant or impairing our results if the prior year reserves prove insufficient.
We believe that our reserves for loss and LAE are sufficient to cover losses that fall within the terms of our policies and agreements with our insured and reinsured customers based on the methodologies used to estimate those reserves. However, we can provide no assurance that actual losses will not (i) be less than or (ii) exceed our total established reserves.
Please refer to Notes 2 “Significant Accounting Policies - Loss and Loss Adjustment Expense Reserves and Recoverable” and 7 “Loss and Loss Adjustment Expense Reserves” of our consolidated financial statements for a more detailed explanation of our loss reserving methodology and the loss development tables by accident year, respectively, as required under U.S. GAAP.
Investments Valuation
We carry our investment in Solasglas at fair value, based on the most recent net asset value obtained from Solasglas’ third-party administrator. Further, Solasglas’ financial statements for the years ended December 31, 2024, 2023, and 2022 were subject to
70
Return to table of contents
an independent audit in which Solasglas’ external auditors issued an unqualified opinion for these years (see “Report of Independent Registered Public Accounting Firm” in the Exhibits).
Other investments in our consolidated balance sheets includes private and unlisted equity securities that do not have readily determinable fair values. We determine these private equity securities’ carrying value based on the original cost, less impairment, plus or minus observable price changes in orderly transactions for an identical or similar investment of the same issuer. At each reporting date, we qualitatively consider whether the investment is impaired on the basis of certain impairment indicators. If we determine that the equity security is impaired on the basis of the qualitative assessment and the estimated fair value is less than the carrying value, we recognize an impairment loss in “Net investment income (loss)” in the consolidated statements of operations. We determine realized gains and losses from other investments based on the specific identification method (by reference to cost or amortized cost, as appropriate). These gains and losses are also included in “Net investment income (loss)” in the consolidated statements of operations.
71
Return to table of contents